Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
6.84 Down 0.02(0.29%) Feb 27, 4:00PM EST
Add to Portfolio
Prev Close:6.86
Open:6.83
Bid:6.84 x 400
Ask:6.93 x 100
1y Target Est:10.92
Beta:0.85
Next Earnings Date:N/A
Day's Range:6.83 - 7.02
52wk Range:4.36 - 8.22
Volume:15,260
Avg Vol (3m):13,237
Market Cap:240.97M
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
TTHIDown 0.29%240.97M
GSKDown 0.88%114.07B
MRKDown 0.71%166.89B
PFEDown 0.78%216.24B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.39
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback